STUDIES ON THE CORONARY DILATOR ACTIONS OF SOME ADENOSINE ANALOGUES
Open accessThe DOI matches its Crossref record.
Abstract
The cardiovascular actions of 23 adenosine analogues have been examined in anaesthetized open thorax dogs; the analogues were substituted in the 2‐position of the purine ring, or in the exocyclic amino group, or were modified in the imidazole or sugar rings. The effects of these compounds on coronary blood flow, peripheral blood pressure, and heart rate were compared with those of adenosine. 9‐β‐d‐Arabinofuranosyladenine had no cardiovascular action; the other analogues on intra‐atrial administration caused an immediate increase in coronary blood flow, the magnitude and duration of which varied with the structures of the analogues. 2‐Fluoro‐, 2‐bromo‐, 2‐isobutylthio‐, 2‐ethylamino‐, and 5′‐deoxy‐5′‐chloro‐ adenosines had coronary dilator potencies equal to or greater than that of adenosine. No relationship was found between the dilator potency of the adenosine analogues and their duration of coronary dilator action. The coronary dilator action of adenosine was potentiated by inosine, 9‐β‐d‐arabinofuranosyladenine, tubercidin, N6‐methyladenosine and 2‐trifluoromethyl‐N6‐methyladenosine. There was no correlation between the substrate specificities of the shorter‐acting analogues for adenosine deaminase or adenosine kinase and their duration of coronary dilator action. It is proposed that in the anaesthetized dog, uptake into tissues is a more important mode of removal of adenosine and adenosine analogues from the vascular system than in activation by adenosine deaminase, that the duration of coronary dilator action of the analogues is related primarily to their specificity for the carrier which mediates adenosine uptake, and that the adenosine carrier is not associated with kinase action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Purinergic Signaling and Blood Vessels in Health and Disease
Burnstock, G., & Ralevic, V. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008029 · Cited by 303
Adenosine A 2A Receptor as a Drug Discovery Target
de Lera Ruiz, M., Lim, Y.-H., & Zheng, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4011669 · Cited by 276
Adenosine and Adenosine Receptor-Mediated Action in Coronary Microcirculation
Zhang, Y., Wernly, B., Cao, X., Mustafa, S. J., Tang, Y., & Zhou, Z. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00859-7 · Cited by 71
Metadata
- Authors
- COBBIN, L. B., EINSTEIN, R., & MAGUIRE, M. H.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1974-01
- Volume
- 50
- Issue
- 1
- Pages
- 25-33
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1982447241
- Cited by
- 54
- References
- 0
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: STUDIES ON THE CORONARY DILATOR ACTIONS OF SOME ADENOSINE ANALOGUES. https://app.cochat.ai/papers/10.1111/j.1476-5381.1974.tb09589.x
- The paper
- COBBIN, L. B., EINSTEIN, R., & MAGUIRE, M. H. (1974). STUDIES ON THE CORONARY DILATOR ACTIONS OF SOME ADENOSINE ANALOGUES. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1974.tb09589.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.